Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria,
published in 1996 by the National Institute of Neurological Disorders and Stroke/Society for …

It has been 30 years since the discovery that repeated electrical stimulation of neural pathways
can lead to long-term potentiation in hippocampal slices. With its relevance to processes …

Background Mutations in LRRK2, the gene that encodes leucine-rich repeat kinase 2, are a
cause of Parkinson's disease (PD). The International LRRK2 Consortium was established to …

Background Consensus criteria for classifying tremor disorders were published by the
International Parkinson and Movement Disorder Society in 1998. Subsequent advances with …

Current criteria for the clinical diagnosis of pathologically confirmed corticobasal
degeneration (CBD) no longer reflect the expanding understanding of this disease and its …

The behavioural and movement disorders reported in 240 patients described in the
literature with lesions affecting the caudate nucleus, putamen and the globus pallidus (lentiform …

Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene have been shown to cause
autosomal dominant Parkinson's disease. Few mutations in this gene have been identified. We …

As there are no biological markers for the antemortem diagnosis of degenerative parkinsonian
disorders, diagnosis currently relies upon the presence and progression of clinical …

The disorder of autosomal dominant nocturnal frontal lobe epilepsy has recently been
identified, and is now delineated in detail. A phenotypically homogeneous group of five families …

Parkinson's disease (PD) is one of the most common neurodegenerative disorders. The
condition causes a heavy burden both on those affected, as well as their families. Accurate …